Cart 0
Compare 0 Wishlist 0
My Account
Menu
₹405 000

Inonza 1mg Injection

Brand: PFIZER LTD
Product Code: MRM_200448
Reviews: (0)
In Stock
₹405 000
Buy in one click
Specifications: (see all)
Manufacturer
PFIZER LTD
Origin of Medicine
United States of America
Price for
1 Vial(s)
Salt Composition
Inotuzumab Ozogamicin
Delivery Delivery from India within 15 days. Payment Pay quickly and conveniently Cumulative discounts Collect bonuses and gifts

Inonza 1mg injection is an anticancer medication with an active ingredient called Inotuzumab ozogamicin. It is used to treat adults with acute lymphoblastic Leukemia. It is intended when patients have failed to respond to other treatments. Acute lymphoblastic Leukemia (ALL) refers to the accumulation of white blood cells that have not matured due to the abnormal production of white blood cells in the bone marrow.  

Do not take Inonza 1mg injection if you are allergic to Inotuzumab ozogamicin or any other ingredients of this medicine, if you have or have any history with any liver disease, such as venoocculusive disease (damaged liver blood vessels), cirrhosis, nodular regenerative hyperplasia (signs and symptoms of portal hypertension due to chronic use of medicine), or active hepatitis (inflammation of the liver) and blood clot. This medicine is not recommended for children and adolescents.  

Before starting the Inonza 1mg treatment, inform your doctor if you have signs and symptoms of tumor lysis syndrome, a low number of blood cells (neutrophils), elevations in amylase or lipase enzymes, or a history of QT interval prolongation. Notify your doctor if you are pregnant or planning to get pregnant during and after the treatment for up to 8 months. Use effective contraception during and after eight months of treatment for women and five months for men. Discuss with your doctor for more fertility concerns. Certain tests will be taken to monitor the blood cell count, liver enzyme, and QT interval.

Uses of Inonza 1mg Injection
  • Acute lymphoblastic Leukemia
  • Therapeutic Effects of Inonza 1mg Injection

    Inonza 1mg injection targets a protein called CD22, which is commonly expressed by blood cancer (ALL) cells. After attaching to this protein, this medicine disturbs the DNA of the cancer cells and eventually kills them.

    Interaction of Inonza 1mg Injection with other drugsInform your healthcare provider about all the medicines you take, including prescription, over-the-counter, nutritional, supplements, and herbal products. In particular, tell your doctor if you are taking medicines for blood pressure or other heart conditions. Certain medications may interact with Inonza 1mg and reduce its effectiveness by causing undesirable side effects. 

    More Information about Inonza 1mg Injection
  • Store Inonza 1mg in the refrigerator (2°C to 8°C)
  • Do not freeze
  • keep the injection away from the reach of children and pets.
  • If you have missed any dosing appointments, inform your doctor and schedule immediately.
  • How to consume Inonza 1mg InjectionA trained doctor or nurse should only administer it. Do not self-administer the Inonza 1mg injection. Your doctor will decide the dose and duration of your treatment based on the disease severity and other factors. It will be given as an intravenous infusion, and you will be monitored carefully for unwanted side effects. 

    Safety Advices for Inonza 1mg Injection

      

    Pregnancy

      

    Your doctor will prescribe Inonza 1mg only if needed, as this medicine might cause harm to the unborn baby. So notify your doctor before starting the preganat if you are preganat or planning to get pregnant. It is advised for women to use contraception during and after the treatment for at least eight months. 

      

    Breast Feeding

      

    It is unsafe to take Inonza 1mg while breastfeeding. Before starting the treatment, notify your doctor if you are breastfeeding. Do not breastfeed during and at least after the two months of the last dose. 

      

    Lungs

      

    It is unknown whether Inonza 1mg is safe to administer in patients with lung problems. Inform your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.

      

    Liver

      

    Inform your physician about any underlying liver disorders before taking Inonza 1mg, as this medication should be used cautiously in liver disease patients. Consult your physician before taking this medicine.

      

    Alcohol

      

    It is unknown whether it is safe to consume alcohol with Inonza 1mg as this medicine makes you feel drowsy. Please consult your doctor for more information.

      

    Driving

      

    Driving while taking Inonza 1mg is unsafe because this medicine might tire you. So avoid driving and operating machinery during this treatment.

    Side Effects of Inonza 1mg InjectionSide effects are unwanted symptoms caused by medicines. Even though all medications cause side effects, not everyone gets them.

    Serious

    • Breathing trouble
    • Chills
    • Rapid weight gain
    • Abnormal liver function values
    • Frequent bleeding and bruising
    • Infusion-related reaction (fever, chill, breathing trouble)
    • Venoocclusive liver disease (rapid weight gain, right upper abdomen pain, swelling of the liver)
    • The lower number of blood cells
    • Tumor lysis syndrome
    • Changes in the electrical activity of the heart

    Common

    • Anaemia
    • Tiredness
    • Infection
    • Bleeding
    • Fever
    • Nausea
    • Headache
    • Abnormal blood values
    • Stomach pain
    • High bilirubin value
    • Low appetite
    • Mouth inflammation
    • Constipation
    • Diarrhea
    • Swelling of abdomen

    Word of AdviceDose adjustments will be made based on the response to the treatment. Pre-medicine will be given to reduce the infusion reactions, keep hydrated, and prevent tumor lysis syndrome and other side effects. There is limited information on the safety of Inonza 1mg in renal failure patients; inform your physician if you have kidney disease. Notify your doctor if you experience any side effect symptoms, as your doctor may change the dosage of this medicine or give additional medicine to reduce the effect of the side effects. Men should use effective contraception during and after the last dose of the treatment. 

    FAQs Q 1. Why is liver enzyme getting elevated during treatment with Inonza 1mg?

    The reason for this elevation is not completely understood, but it is thought to be related to the drug's effects on certain enzymes involved in liver function.

    Q 2. Do we have to use contraception even after the treatment with Inonza 1mg?

    Yes, it is advised to use effective contraception even after the last dose of Inonza 1mg; 8 months for women and five months for men.

    Q 3. What should I inform the doctor about before starting the Inonza 1mg?

    Inform about underlying medical conditions, especially the history of blood clots and liver-related conditions, before starting Inonza 1mg .

    Q 4. Can I Inonza 1mg in children?

    No, Only limited information is available about Inonza 1mg usage in children. So it is advised not to use it in children. Talk to your doctor for more information.

    Q 5. Do we have to take any tests during Inonza 1mg treatment?

    Yes, your physician might regularly take blood tests to monitor your blood count and liver enzymes. Additionally, with an electrocardiogram, your electrolyte will also be monitored during the treatment with Inonza 1mg

    Fact Box of Inonza 1mg Injection

    Molecule name:  Inotuzumab ozogamicin

    Therapeutic class: Antineoplastic 

    Pharmacological class:  Monoclonal antibodies

    Indication:  Acute lymphoblastic leukemia

    Основные характеристики
    Manufacturer
    PFIZER LTD
    Origin of Medicine
    United States of America
    Price for
    1 Vial(s)
    Salt Composition
    Inotuzumab Ozogamicin
    Reviews
    0/ 5
    average product rating
    0
    0
    0
    0
    0
    There are no reviews for this product. Be the first to leave your review.